Key Takeaways
- On March 23, ARK Invest divested 39,362 shares of Bullish (BLSH) valued at approximately $1.56 million through its ARKK and ARKW ETFs
- The crypto exchange stock appreciated 4.16% during the same trading session, ending near $39.55
- Just three days prior on March 20, ARK had unloaded 103,379 BLSH shares representing roughly $3.93 million
- These sales follow ARK’s substantial February 2026 accumulation of approximately 2.1 million BLSH shares totaling $58–$60 million across nine trading days
- Wall Street analysts maintain a Moderate Buy rating on BLSH with a consensus price target of $47.83, suggesting approximately 20.9% potential upside
Cathie Wood’s investment firm ARK Invest divested a total of 39,362 shares of Bullish (BLSH) on Monday, March 23, representing approximately $1.56 million in value, during a trading session that saw the cryptocurrency exchange stock appreciate 4.16%.
The divestment occurred across two exchange-traded funds: ARK Innovation ETF (ARKK) disposed of 31,154 shares, while ARK Next Generation Internet ETF (ARKW) liquidated 8,208 shares. The stock settled at approximately $39.55 at the close of trading.
This transaction represents the second notable sale within a week. On March 20, ARK had previously reduced its BLSH position by 103,379 shares worth approximately $3.93 million — a significantly larger divestment that received less attention than Monday’s trade.
Combined, the two separate transactions total 142,741 shares with an aggregate value of approximately $5.5 million. These sales represent a fraction of ARK’s substantial stake accumulated through consistent buying activity.
During February 2026, ARK executed an intensive nine-day accumulation campaign in BLSH, acquiring roughly 2.1 million shares valued between $58 and $60 million. This buying activity occurred as the stock experienced downward pressure following its earnings announcement.
Financial Performance Breakdown
Bullish’s fourth-quarter 2025 results showed adjusted revenue reaching $92.5 million with adjusted EBITDA of $44.5 million, both representing year-over-year growth. The company posted a net loss of $563.6 million, though adjusted net income strengthened to $28.9 million.
Digital asset trading volume totaled $64.3 billion during the quarter, representing a modest decline. Management provided 2026 guidance projecting subscription, services, and other revenue between $220 million and $250 million.
For the full year, adjusted operating expenses are forecasted to range from $210 million to $230 million.
Strategic Portfolio Rebalancing
The recent share reduction appears to be a tactical portfolio adjustment rather than a fundamental shift in investment thesis. ARK Invest has demonstrated a consistent pattern of accumulating BLSH shares during price weakness and reducing positions during strength — Monday’s transaction aligns perfectly with this established strategy, occurring as shares rallied over 4%.
Simultaneously, ARK redirected capital toward biotechnology opportunities. On the same day, the firm acquired 98,722 shares of 10X Genomics (TXG) valued at $1.89 million, with TXG also gaining 4.08% during the session.
Cryptocurrency-related equities like BLSH typically exhibit significant volatility correlated with Bitcoin price movements and regulatory developments, making them logical candidates for strategic profit-taking following substantial price appreciation.
According to TipRanks data, BLSH maintains a Moderate Buy consensus rating supported by four Buy recommendations and two Hold ratings. The average Wall Street price target stands at $47.83, representing approximately 20.9% upside potential from current trading levels.
